Intercept Pharmaceuticals Inc $223.99

up +2.99


28/7/2014 05:21 PM  |  NASDAQ : ICPT  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get ICPT Trend Analysis - it has outperformed the S&P 500 by 372%

Partner Headlines

  1. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  2. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  3. Benzinga's Top Initiations

    Benzinga
  4. Analysts Comment On Intercept Amid Share Decline Following FLINT Data Delay

    Benzinga
  5. Top Healthcare Movers For June 9, 2014

    Benzinga
  6. Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings

    Benzinga
  7. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., Micron Technology ...

    GuruFocus
  8. Intercept Issues Preclinical Data Showing OCA's Potential Role in Preventing ...

    Benzinga
  9. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  10. Market Wrap For March 17: Investors Focused On Economic Data Instead Of ...

    Benzinga
  11. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  12. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  13. Top Trending Tickers On StockTwits For March 17

    Benzinga
  14. Benzinga's Top #PreMarket Losers

    Benzinga
  15. Morning Gainers for Friday, March 14, 2014

    Benzinga
  16. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  17. Shares of Intercept Pharma Rise as BofA Sees US, EU Regulators Giving A ...

    Benzinga
  18. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  19. Precious Metals, Health Care Led Mutual Funds In Feb.

    IBD
  20. Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2014?

    Benzinga
  21. Mid-Morning Market Update: Markets Rise; Bank of America Profit Beats Estimates

    Benzinga
  22. Benzinga's Top #PreMarket Gainers

    Benzinga
  23. Market Wrap For January 14: Markets Rebound On Earnings Season Kickoff

    Benzinga
  24. Mid-Afternoon Market Update: Markets Continue Rally as Tesla Guidance Lifts ...

    Benzinga
  25. Stocks Up In Afternoon; Tesla Soars On Strong Sales

    IBD
  26. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  27. Morning Market Losers

    Benzinga
  28. Benzinga's Top #PreMarket Losers

    Benzinga
  29. Intercept Reports Additional Details About FLINT Clinical Trial of OCA ...

    Benzinga
  30. Intercept to Present at the JP Morgan Healthcare Conference on Wednesday, ...

    Benzinga
  31. Market Wrap For January 10: Job Growth Weak, But Unemployment Falls

    Benzinga
  32. Mid-Afternoon Market Update: Plug Rises on Secondary Pricing as Markets ...

    Benzinga
  33. Mid-Day Market Update: Abercrombie & Fitch Surges On Strong Outlook; Sears ...

    Benzinga
  34. Intercept Shares Skyrocket 500% This Week

    FoxBusiness
  35. Mid-Morning Market Update: Markets Drop; Alcoa Q4 Earnings Miss Estimates

    Benzinga
  36. Bank of America Reiterates on Intercept Pharmaceuticals

    Benzinga
  37. Benzinga's Volume Movers

    Benzinga
  38. Stocks Hitting 52-Week Highs

    Benzinga
  39. Citi Maintains on Intercept Pharmaceuticals

    Benzinga
  40. Stock Futures Trim Early Gains; Oriental Education Leads IBD 50

    IBD
  41. Benzinga's Top #PreMarket Gainers

    Benzinga
  42. Intercept drug hits endpoint

    IBD
  43. Mid-Afternoon Market Update: Markets Moving Sideways Ahead of Alcoa Report

    Benzinga
  44. Mid-Day Market Update: U.S. Stocks Turn Red; Bed Bath & Beyond Shares Decline ...

    Benzinga
  45. Intercept Pharma Liver-Disease Drug Scores In Trial

    IBD
  46. Benzinga's Volume Movers

    Benzinga
  47. Morning Market Movers

    Benzinga
  48. Benzinga's Top #PreMarket Gainers

    Benzinga
  49. Intercept Pharmaceutical Shares Skyrocket after Oppenheimer's Data "Optimism"

    Benzinga
  50. Intercept Prices 1.5M Share Offering at $62.50/Share

    Benzinga
Trading Center